Glenda Mejos
Gerontology · San Antonio, TXNPI 1346738333
Payments from drug & device makers
Across 154 payments — averaging $20.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$585
- Lilly USA, LLC$396
- Bayer$305
- Dexcom, Inc.$131
- AstraZeneca$116
- plus $276 from 7 others
What the payments were for
- Food & beverage$3,097100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 80 | $1,289 |
| Novo Nordisk | 22 | $585 |
| Lilly USA, LLC | 13 | $396 |
| Bayer | 12 | $305 |
| Dexcom, Inc. | 6 | $131 |
| AstraZeneca | 7 | $116 |
| Pfizer | 4 | $69 |
| Amgen | 3 | $50 |
| Antares Pharma, Inc. | 2 | $42 |
| Shield Therapeutics Inc | 2 | $40 |
| Tactile Systems Technology Inc | 1 | $30 |
| Abbott | 1 | $24 |
| GSK | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,097 in reported general payments places this provider in the 85th percentile of 653 gerontology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 41 | $59,947 |
| MounjaroTirzepatide | 21 | $25,152 |
| FarxigaDapagliflozin Propanediol | 26 | $22,957 |
| Levothyroxine Sodium | 109 | $1,009 |
| Atorvastatin Calcium | 84 | $1,008 |
| Rosuvastatin Calcium | 50 | $926 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $736 |
| Clobetasol Propionate | 13 | $675 |
| Losartan Potassium | 54 | $612 |
| Valsartan | 22 | $610 |
| Fluoxetine Hcl | 14 | $557 |
| Gabapentin | 26 | $476 |
| Lisinopril | 60 | $437 |
| Fluticasone Propionate | 31 | $409 |
| Metformin Hcl ErMetformin Hcl | 41 | $365 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $585 | $59,94741 claims |
| Lilly USA, LLCMounjaro | $396 | $25,15221 claims |
| AstraZenecaFarxiga | $116 | $22,95726 claims |
| AbbVieSynthroid | $1,289 | $31013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 653 gerontology providers in Texas.
Other gerontology in San Antonio
- Cecilia OrtizSan Antonio$13K
- Bianca LopezSan Antonio$11K
- Alexis SantangeloSan Antonio$9K
- Juliet GatobuSan Antonio$7K
- Ashlee DuggerSan Antonio$7K
- Amy RomickSan Antonio$5K
- Diana GarzaSan Antonio$4K
- Kimberly WelchCoppell$113K
- Tiffany KesslerDallas$84K
- Jennifer WestFort Worth$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.